Quinolones in 2005: an update
Top Cited Papers
- 1 April 2005
- journal article
- research article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (4) , 256-280
- https://doi.org/10.1111/j.1469-0691.2005.01131.x
Abstract
No abstract availableKeywords
This publication has 263 references indexed in Scilit:
- Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United StatesDiagnostic Microbiology and Infectious Disease, 2005
- Assessment of pharmacokinetic–pharmacodynamic target attainment of gemifloxacin against Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 2005
- Optimizing fluoroquinolone utilization in a public hospital: a prospective study of educational interventionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Prevalence of Antibiotic Resistance in Anaerobic Bacteria: Worrisome DevelopmentsClinical Infectious Diseases, 2004
- Quinolone Molecular Structure‐Activity Relationships: What We Have Learned about Improving Antimicrobial ActivityClinical Infectious Diseases, 2001
- The safety profile of the fluoroquinolonesClinical Therapeutics, 2000
- In Vitro Exchange of Fluoroquinolone Resistance Determinants betweenStreptococcus pneumoniaeand Viridans Streptococci and Genomic Organization of theparE‐parCRegion inS. mitisThe Journal of Infectious Diseases, 1999
- Mechanisms of fluoroquinolone resistanceDrug Resistance Updates, 1999
- Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophagesJournal of Antimicrobial Chemotherapy, 1990
- In vitro activity of ciprofloxacin, norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983